Biostatistical considerations for head and neck cancer research

  • Robert Makuch
  • Mary Johnson
Part of the Cancer Treatment and Research book series (CTAR, volume 22)


The proper application of statistical principles to research in clinical oncology can have a tremendous impact on the validity and persuasiveness of results. The biomedical literature contains some very comprehensive discussions of design considerations for clinical studies in cancer and guidelines for collecting and evaluating data from such trials (e.g., see [1,2]).


Neck Dissection Induction Chemotherapy Treatment Assignment Radical Neck Dissection Death Time 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Friedman LM, Furberg CD, DeMets DL: Fundamentals of Clinical Trials. London, John Wright, 1981.Google Scholar
  2. 2.
    Proceedings of the Symposium on Designs for Clinical Cancer Research. Cancer Treat Rep. 64: 363–538, 1980.Google Scholar
  3. 3.
    Byar DP, Simon RM, Friedewald WT, Schlesselman JJ, DeMets DL, Ellenberg JH, Gail MH, Ware JH: Randomized clinical trials. N Eng J Med 295: 74–80, 1976.CrossRefGoogle Scholar
  4. 4.
    Gehan EA, Freireich EJ: Non-randomized controls in cancer clinical trials. N Eng J Med 290: 198–203, 1974.CrossRefGoogle Scholar
  5. 5.
    Byar DP: Necessity and justification of randomized clinical studies. In: Tagnon HJ, Staquet MJ (eds) Controversies in Cancer Treatment. New York, Mason Publishing, 1979, pp75–82.Google Scholar
  6. 6.
    Shaw LW, Chalmers TC: Ethics in cooperative clinical trials. Ann NY Acad Sciences 169: 487–495, 1970.CrossRefGoogle Scholar
  7. 7.
    Cox DR: Analysis of Binary Data. New York, Methuen Co., 1970.Google Scholar
  8. 8.
    Cox DR: Regression models and life tables (with discussion). J Royal Stat Soc B 34:187–220, 1972.Google Scholar
  9. 9.
    Farewell VT, D’Angio GJ: A simulated study of historical controls using real data. Biometrics 37: 169–176, 1981.PubMedCrossRefGoogle Scholar
  10. 10.
    Pocock SJ: Randomized clinical trials (letter). Brit Med J 1: 1661, 1977.PubMedCrossRefGoogle Scholar
  11. 11.
    Zelen M: A new design for randomized clinical trials. N Eng J Med 300: 1273–1275, 1979.CrossRefGoogle Scholar
  12. 12.
    Zelen M: Strategy and alternate randomized designs in cancer clinical trials. Cancer Treat Rep 66: 1095–1100, 1982.PubMedGoogle Scholar
  13. 13.
    Fleming TR: Historical controls, data banks, and randomized trials in clinical research: A review. Cancer Treat Rep 66: 1101–1106, 1982.PubMedGoogle Scholar
  14. 14.
    Peto R: Clinical trial methodology. Biomedicine 28: 24–36, 1978.PubMedGoogle Scholar
  15. 15.
    Schoenfeld D, Gelber R: Designing and analyzing clinical trials which allow institutions to randomize patients to a subset of the treatments under study. Biometrics 35: 825–829, 1979.PubMedCrossRefGoogle Scholar
  16. 16.
    Makuch RW, Simon RM: A note on the design of multi-institution three-treatment studies. Cancer Clin Trials 1: 301–303, 1978.PubMedGoogle Scholar
  17. 17.
    Zelen M: The randomization and stratification of patients to clinical trials. J Chron Dis 27: 365–375, 1974.PubMedCrossRefGoogle Scholar
  18. 18.
    Freiman JA, Chalmers TC, Smith H, Jr., et al.: The importance of beta, the type II error and sample size in the design and interpretation of the randomized control trial: Survey of 71 4 negative’ trials. N Eng J Med 299: 690–694, 1978.CrossRefGoogle Scholar
  19. 19.
    Casagrande JT, Pike MC, Smith PG: An improved formula for calculating sample sizes for comparing two binomial distributions. Biometrics 34: 483–486, 1978.PubMedCrossRefGoogle Scholar
  20. 20.
    Makuch RW, Simon RM: Sample size requirements for evaluating a conservative therapy. Cancer Treat Rep 62: 1037–1040, 1978.PubMedGoogle Scholar
  21. 21.
    George SL, Desu MM: Planning the size and duration of a clinical trial studying the time to some critical event. J Chron Dis 27: 15–24, 1974.PubMedCrossRefGoogle Scholar
  22. 22.
    Makuch RW, Simon RM: Sample size requirements for comparing time-to-failure among k treatment groups. J Chron Dis 35: 861–868, 1982.PubMedCrossRefGoogle Scholar
  23. 23.
    Rubinstein LV, Gail MH, Santner TJ: Planning the duration of a comparative clinical trial with loss to follow–up and a period of continued observation. J Chron Dis 34: 469–479, 1981.PubMedCrossRefGoogle Scholar
  24. 24.
    Peto R, Pike MC, Armitage P, Breslow NE, Cox DR, Howard SV, Mantel N, McPherson K, Peto J, Smith PG: Design and analysis of randomized clinical trials requiring prolonged observation of each patient. Brit J Cancer 34:585–612, 1976 and 35: 1–39, 1977.Google Scholar
  25. 25.
    Grizzle JE: A note on stratifying versus complete random assignment in clinical trials. Controlled Clin Trials 3: 365–368, 1982.PubMedCrossRefGoogle Scholar
  26. 26.
    Brown BW, Jr: Statistical controversies in the design of clinical trials –some personal views. Controlled Clin Trials 1: 13–27, 1980.CrossRefGoogle Scholar
  27. 27.
    Pocock SJ, Simon RM: Sequential treatment assignment with balancing for prognostic factors in the controlled clinical trial. Biometrics 31: 103–115, 1975.PubMedCrossRefGoogle Scholar
  28. 28.
    Efron B: Forcing a sequential experiment to be balanced. Biometrika 58: 403–417, 1971.CrossRefGoogle Scholar
  29. 29.
    Kaplan EL, Meier P: Nonparametric estimation from incomplete observations. J Am Stat Assn 458–481, 1958.Google Scholar
  30. 30.
    Gehan EA: A generalized Wilcoxon test for comparing arbitrarily singly-censored samples. Biometrika 52: 203–224, 1965.PubMedGoogle Scholar
  31. 31.
    Mantel N: Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemo Rep 50: 163–170, 1966.Google Scholar
  32. 32.
    Hankey BF, Myers MH: Evaluating differences in survival between two groups of patients. J Chron Dis 24: 523–531, 1971.PubMedCrossRefGoogle Scholar
  33. 33.
    Makuch RW: Adjusted survival curve estimation using covariates. J Chron Dis 35:437–443, 1982.Google Scholar
  34. 34.
    Tukey JW: Some thoughts on clinical trials, especially problems of multiplicity. Science 198: 679–684, 1977.PubMedCrossRefGoogle Scholar
  35. 35.
    McPherson K: Statistics: The problem of examining accumulating data more than once. N Eng J Med 290: 501–502, 1974.CrossRefGoogle Scholar
  36. 36.
    O’Brien PC, Fleming TR: A multiple testing procedure for clinical trials. Biometrics 35: 549–556, 1979.PubMedCrossRefGoogle Scholar
  37. 37.
    Rubinstein LV, Gail MH: Monitoring rules for stopping accrual in comparative survival studies. Controlled Clin Trials 3: 325–343, 1982.PubMedCrossRefGoogle Scholar

Copyright information

© Martinus Nijhoff Publishers, Boston 1984

Authors and Affiliations

  • Robert Makuch
  • Mary Johnson

There are no affiliations available

Personalised recommendations